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Abstract
Motivation: Acute myeloid leukemia (AML) is one of the most common hematological malignan-
cies, characterized by high relapse and mortality rates. The inherent intra-tumor heterogeneity in
AML is thought to play an important role in disease recurrence and resistance to chemotherapy.
Although experimental protocols for cell proliferation studies are well established and widespread,
they are not easily applicable to in vivo contexts, and the analysis of related time-series data is
often complex to achieve. To overcome these limitations, model-driven approaches can be
exploited to investigate different aspects of cell population dynamics.
Results: In this work, we present ProCell, a novel modeling and simulation framework to investi-
gate cell proliferation dynamics that, differently from other approaches, takes into account the in-
herent stochasticity of cell division events. We apply ProCell to compare different models of cell
proliferation in AML, notably leveraging experimental data derived from human xenografts in
mice. ProCell is coupled with Fuzzy Self-Tuning Particle Swarm Optimization, a swarm-intelligence
settings-free algorithm used to automatically infer the models parameterizations. Our results pro-
vide new insights on the intricate organization of AML cells with highly heterogeneous proliferative
potential, highlighting the important role played by quiescent cells and proliferating cells character-
ized by different rates of division in the progression and evolution of the disease, thus hinting at
the necessity to further characterize tumor cell subpopulations.
Availability and implementation: The source code of ProCell and the experimental data used in
this work are available under the GPL 2.0 license on GITHUB at the following URL: https://github.
com/aresio/ProCell.
Contact: piergiuseppe.pelicci@ieo.it or daniela.besozzi@unimib.it
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Acute myeloid leukemia (AML) is one of the most frequent hemato-
logical malignancies in adults, with variable prognosis among
patients and a high mortality rate. Despite the advances in the field,
the backbone of therapeutic intervention for non-promyelocytic
AML has remained essentially unaltered for the last 40 years. About
60–85% of patients below the age of 60 respond to therapy and ini-
tially achieve complete remission (CR). Nevertheless, most patients
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will relapse within 3 years after diagnosis. Salvage therapy, in the
form of aggressive chemotherapy or allogeneic hematopoietic stem
cell (HSC) transplantation, may still be an option at this stage, but
the prognosis after the first recurrence becomes dismal, especially
when relapse occurs after a brief CR period (Do¨hner et al., 2015). It
is thought that disease recurrence is caused by the persistence of che-
moresistant leukemic cells at CR, presumably residing within the
quiescent leukemia stem cell (LSC) compartment.
It has been previously shown that only a fraction of distinguish-
able leukemic cells, the LSCs, has reproducibly high clonogenic
capacity and the ability to propagate the disease upon transplant-
ation in recipient mice (Bonnet and Dick, 1997). Among the LSC
population, a subpopulation of cell-cycle restricted cells appears to
play a pivotal role in both tumor initiation and maintenance (Viale
et al., 2009). This quiescent LSC subset could also evade current
chemotherapeutic approaches, which mainly target highly prolif-
erative cells, and initiate disease relapse. Indeed, quiescence has
been previously associated through indirect evidence with chemore-
sistance in AML (Ishikawa et al., 2007; Saito et al., 2010). To in-
vestigate the dynamic regulation of quiescent LSCs in vivo and to
monitor their proliferation kinetics over time, we generated pa-
tient-derived xenografts (PDX) of human AML and implemented a
label-retaining assay for in vivo cell division tracking of leukemic
cell populations with different proliferation potential. For this pur-
pose, human leukemic blasts were labeled, by means of lentiviral
transduction, with histone 2 B (H2B) - green fluorescent protein
(GFP) and transplanted in immunocompromised mice. The expres-
sion of the fusion protein is regulated by a Tet-Off promoter sys-
tem, allowing for conditional suppression in the presence of
tetracycline or tetracycline derivatives (e.g. doxycycline-dox).
Thus, the dilution of the H2B-GFP signal in the presence of dox
(chasing period) can be used to infer information on the relative
contribution of cells with different cell-cycle kinetics in a given
AML population, and to estimate their respective proliferation
rates during the progression of the disease.
The available experimental methods may not be enough to quan-
tify and assess cell proliferation dynamics, because of the complexity
of data analysis, the lack of single-cell resolution data, and the inher-
ent difficulties in applying them in vivo. Ideally, the visual identifica-
tion of each cell generation as a distinct peak in the H2B-GFP
fluorescence histogram would require analyses of a starting popula-
tion of AML blasts (prior to any dox administration) that express
homogeneously H2B-GFP and divide in a synchronous manner.
Expectedly, individual AML cells are heterogeneous with respect to
their cell-cycle properties, and patterns of H2B-GFP expression and
dilution in our AML model were highly variable (see Supplementary
Section S1 for further information). To investigate the heterogeneity
and high complexity of an asynchronously dividing cell population
monitored in vivo, we decided to apply computational modeling on
flow cytometry data obtained from bone marrow (BM) samples
at three time points during a chasing period of 3 weeks (days 0, 10
and 21).
Several mathematical models of cancer growth have been pro-
posed in literature, relying on Ordinary Differential Equations to de-
scribe different dynamics of cell proliferation (e.g. exponential,
power law, logistic) (Sarapata and de Pillis, 2014; Zheng et al.,
2013). Among them, some works investigated the occurrence of sub-
populations to obtain a more accurate description and novel insights
about tumor evolution (see, for instance, Ibrahim-Hashim et al.,
2017; Kansal et al., 2000), whereas other works are based on cellu-
lar automata or agents to describe emergent and self-organizing dy-
namics (d’Inverno and Saunders, 2005). Here, following a different
strategy from previous works (Foudi et al., 2009; Hross and
Hasenauer, 2016; Luzyanina et al., 2014; Takizawa et al., 2011),
we propose a novel modeling and simulation approach, called
ProCell, which takes into account the inherent stochasticity of cell
division events. We apply ProCell to investigate the possible occur-
rence of different subpopulations of cells in a given AML popula-
tion. Namely, we define and compare four computational models
to study the differences between the presence of quiescent and pro-
liferating cells, with an additional characterization of slowly and
fast proliferating cells. To the best of our knowledge, this is also the
first attempt of modeling in vivo heterogeneous proliferation kinet-
ics in PDX. The four models required a proper parameterization to
run meaningful simulations of cell proliferation in AML. The cali-
bration of the models against the experimental data (i.e. the H2B-
GFP fluorescence histogram at any given time point) is a necessary
step to determine which model is more adequate to explain the
observed cell populations in each BM sample. Therefore, we carried
out a parameter estimation task, coupled with the stochastic algo-
rithm of cell division implemented in ProCell, to determine the
model parameters leading to a simulation outcome able to fit the
experimental data.
The problem of evaluating how much a simulation outcome fits
with the target fluorescence histogram is a non-convex, non-linear
and noisy minimization problem. In this context, global optimiza-
tion methods can be efficiently exploited, as they are able to intelli-
gently explore the search space of possible model parameterizations
and to converge to an optimal solution (Moles et al., 2003). In this
work, we exploit Fuzzy Self-Tuning PSO (FST-PSO, Nobile et al.,
2018b), an efficient and settings-free variant of the global optimiza-
tion method Particle Swarm Optimization (PSO, Poli et al., 2007).
Although classic PSO was shown to be the most suitable algorithm
for parameter estimation (Dra¨ger et al., 2009; Nobile et al., 2012),
a special modification of FST-PSO was proven to outperform all
the other methods for this particular application (Nobile et al.,
2018a).
The four models of cell proliferation in AML were calibrated
and validated by using H2B-GFP fluorescence histograms of BM
samples measured after 10 and 21 days of chasing, respectively. Our
results show that the model accounting for the coexistence of three
subpopulations of cells—i.e. quiescent, slowly and fast proliferating
cells—yields the best fit against the experimental target data at 10
days. Moreover, this model provides the best prediction of the distri-
bution of AML cells after 21 days of chasing, further supporting the
idea that both quiescent and proliferating cells contribute to disease
progression in AML.
2 Materials and methods
2.1 Experimental protocol
The experimental strategy is based on the xenotransplantation of
human AML blasts infected with a Tet-Off inducible lentivirus that
encodes the H2B-GFP fusion protein (Falkowska-Hansen et al.,
2010). H2B-GFP expression in the transduced AML PDX cells is
under the control of a tetracycline-responsive promoter element
(TRE), which is in turn regulated by a tetracycline-controlled trans-
activator protein (tTA). In the absence of tetracycline or tetracycline
derivatives (e.g. dox), tTA binds to TRE and H2B-GFP is stably
expressed in the infected cells. Upon dox administration, tTA can no
longer bind to the TRE and, consequently, H2B-GFP expression is
shut off. The prolonged suppression of H2B-GFP expression by
in vivo dox administration (chasing period), enables the
Modeling cell proliferation in AML 3379
D
ow
nloaded from
 https://academ
ic.oup.com
/bioinform
atics/article-abstract/35/18/3378/5308598 by U
N
IVER
SITA' D
EG
LI STU
D
I D
I M
ILAN
O
 user on 17 Septem
ber 2019
identification of leukemic cell populations endowed with different
label-retaining capacity, which is expected to correlate with their
cycling properties. Further details on the characteristics of the bio-
logical model adopted in this work and the experimental setup are
reported in Supplementary Section S1.
Dox was administered to the experimental animals engrafted
with H2B-GFP expressing blasts through specially modified feed
(containing 625 mg dox per kg of pellets). BM cells were collected
from dox-treated and -untreated mice at three time points during
the chasing period (0, 10 and 21 days) and analyzed by flow cytome-
try, using FACSCaliburTM (BD). Alive cells were identified based on
physical parameters (forward scatter and side scatter, which relate
to cell size and content, respectively). For each BM sample, flow
cytometry data were acquired for a maximum of 70 000 alive cells.
This sampling process means that the data obtained do not reflect
the absolute number of cells expected to be generated by the expo-
nential expansion of the starting population at day 0 (see
Supplementary Section S2). Human blasts were further distinguished
from the murine BM niche cells using antibodies specific for the
human CD45 surface marker (allophycocyanin APC fluorochrome
conjugated, clone 2D1, BD). A separate population of non-infected
(NI) AML blasts was used as a negative control to set the GFP fluor-
escence background threshold, below which any measurement is
attributed to autofluorescence and the cells are considered as GFP-
negative (GFPneg, see Supplementary Section S2).
The conditional repression of H2B-GFP expression, upon dox
treatment in vivo, resulted in a gradual loss of the intensity of the
GFP fluorescent signal in proliferating cells. In fact, in the presence
of dox, at each cell division, the H2B-GFP protein is expected to be
equally distributed to the two daughter cells, thus allowing monitor-
ing of the number of cell divisions that any given cell has undergone,
and the identification of quiescent/slow-proliferating cells. The
histogram of the fluorescence intensity of the GFP-positive (GFPpos)
cells was then generated using FlowJoTM v10 (see Supplementary
Section S2). GFPneg cells were excluded from further analyses, as
their GFP fluorescence values are not informative for the inference
of their proliferative history. FlowJo’s proliferation platform was
used for the estimation of the number of cell divisions that can be
monitored, starting from the original population (day 0), and
searching for peaks with diminishing fluorescence with an approxi-
mate ratio of 0.5 per generation and peak coefficient of variation
(peak CV) of 4–7%. In accordance with the literature (Falkowska-
Hansen et al., 2010), we found that our H2B-GFP expressing AML
model allows tracking of up to eight rounds of cell division before
losing any detectable GFPpos signal.
In vivo studies were performed after approval from the fully
authorized animal facility of the Department of Experimental
Oncology, notification of the experiments to the Ministry of Health
(as required by the Italian Law) (IACUCs No 18/2013) and in accord-
ance to EU directive 2010/63. Human samples were collected from
patients whose informed consent was obtained in writing according to
the policies of the Ethics Committee of the European Institute of
Oncology and regulations of Italian Ministry of Health. The studies
were conducted in full compliance with the Declaration of Helsinki.
2.2 Modeling cell proliferation in AML
Four computational models describing cell proliferation were
defined to investigate the possible coexistence of different subpopu-
lations of AML cells: quiescent cells, proliferating cells, slowly pro-
liferating cells, fast proliferating cells. In each model, a specific
configuration of cell subpopulations was considered, to predict
whether cells proliferated (fast or slowly) or remained quiescent in
a given BM sample. Namely, in Model #1, we assume the absence
of quiescent cells and the occurrence of proliferating cells only,
without any distinction about their rate of division. In Model #2,
we assume the presence of both quiescent cells and proliferating
cells, without any distinction about their rate of division. In Model
#3, we assume the presence of quiescent cells and two different sub-
populations of proliferating cells, characterized by slow and fast
rates of division. Finally, in Model #4, we assume the absence of
quiescent cells and the occurrence of slowly and fast proliferating
cells. These four models were defined in order to assess the actual
existence of quiescent cells in the AML sample data, and the pres-
ence of proliferating cells that could be characterized or not by dif-
ferent rates of division.
The probability distribution of the division times of proliferat-
ing cells is still poorly characterized, given the inherent variability
between cells belonging to distinct species, tissues, or grown in dif-
ferent conditions, and the lack of studies regarding this matter
(Kinjyo et al., 2015; Stukalin et al., 2013). Since an agreement has
still to be reached, especially in the case of human primary cells, for
the sake of simplicity we assume that the division interval of (slow-
ly and fast) proliferating cells is a random variable with a truncated
normal distribution Nðl; rÞ, for some mean l and standard devi-
ation (SD) r, whose left tail is limited to zero (i.e. values lower than
zero are rejected and re-sampled); in contrast, quiescent cells do not
divide by definition. These parameters, and the proportions of cell
types in each model, are unknown. Table 1 summarizes the model
parameters that had to be estimated, as described in Section 3.2.
We also assume that cells do not change their proliferating rate as a
consequence of cell division: any (slowly or fast) proliferating cell
will generate, respectively, two (slowly or fast) proliferating daugh-
ter cells. Any cell that divides during the chasing period, leads to
the generation of two daughter cells with half of the fluorescence
intensity. Cells cannot re-gain fluorescence in the presence of dox.
H2B-GFP is stable for the period of the 3 weeks we study here,
meaning no loss of fluorescence intensity is expected for other rea-
sons than cell division.
The simulation outcomes of each model were compared with ex-
perimental data for model calibration and validation. The data con-
sist of histograms of fluorescence levels measured at 0, 240 and
504 h, as described in Section 2.1. In what follows we denote a
histogram HðtÞ ¼ fðu1;w1Þ; :::; ðuM;wMÞg as a finite set of ordered
pairs where M is the number of different fluorescence levels in a
given experimental dataset and, for each i ¼ 1; . . . ;M; ui and wi de-
note the ith fluorescence level and the frequency of the ith
Table 1. Model parameters to be estimated: proportion of cells (p),
mean division interval (l), SD of division interval (r)
Quiescent Proliferating Slowly
proliferating
Fast
proliferating
pq pp lp rp ps ls rs pf lf rf
Model #1  
Model #2  a  
Model #3  b   c  
Model #4 d     
aEqual to 1  pq.
bEqual to 1  ðð1  pqÞpf Þ.
cEstimated on the remainder 1  pq.
dEqual to 1  pf .
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fluorescence level, respectively, measured at time t. The fluorescence
levels satisfy the condition that ui < uiþ1; for each
i ¼ 1; . . . ;M 1.
The main assumption of our modeling approach is that every
time a proliferating cell with a fluorescence level ui divides, it gener-
ates two daughter cells whose fluorescence levels are equal to ui=2,
because of the even distribution of H2B-GFP. The division events
are stochastically simulated (see Section 3.1) to determine which
configuration of cell subpopulations better fits with the experimen-
tal data. Each cell occurring in the initial population is explicitly
tracked during the simulation until its fluorescence level reaches a
minimum threshold umin. Quiescent cells naturally keep their fluor-
escence levels unaltered throughout the simulation.
2.3 Fuzzy Self-Tuning Particle Swarm Optimization
PSO is an iterative stochastic population-based meta-heuristics
inspired by the collective movement of fish and birds (Poli et al.,
2007). Specifically, in PSO a swarm of P candidate solutions (named
particles), each one identified by a position vector x, moves inside a
bounded D-dimensional search space, cooperating to converge to
the global best solution of the optimization problem. Traditionally,
the global exploration and local exploitation behaviors of particles
are controlled by two settings, the cognitive attractor Ccog 2 Rþ
and the social attractor Csoc 2 Rþ. Moreover, the velocity of par-
ticles is limited on each dimension of the search space by
using a maximum velocity value vmax ¼ ðvmax1 ; . . . ; vmaxD Þ, with
vmaxd 2 Rþ; d ¼ 1; . . . ;D, and modulated by an inertia factor w 2
R
þ to avoid chaotic behaviors in the swarm. The goodness of the
solutions identified by PSO strongly depends on the accurate selec-
tion of its functioning settings, that is, Ccog;Csoc;w and vmaxd (for
each d ¼ 1; . . . ;D). However, such settings are problem-dependent
and require a massive number of trials to be determined. To bypass
this issue, in this work we rely on FST-PSO, a settings-free variant of
PSO that leverages fuzzy logic to dynamically adjust the functioning
settings of each particle. FST-PSO was empirically shown to be com-
petitive with state-of-the-art methods (Nobile et al., 2018b), espe-
cially for the parameter estimation problem (Nobile et al., 2018a).
In FST-PSO, the search space is bounded to avoid the divergence
of candidate solutions towards infinity; in particular, the algorithm
assumes damping boundary conditions (Xu and Rahmat-Samii,
2007). The ranges of parameter values used to define the search
space for the four models of cell proliferation in AML are given in
Table 2. The rationale for the choice of these intervals is based on
the analysis of the experimental histograms:
• if the division rate of proliferating cells was longer than 21 days,
then the initial histogram (i.e. at t¼0 days) would be identical to
the histograms measured at t¼21 days, and cells would appear
as quiescent cells. Thus, 504 h was selected as the upper bound
for the mean of the division interval for both proliferating and
slowly proliferating cells;
• if the division rate of proliferating cells was shorter than 30 h,
then the unthresholded experimental histogram measured at
t¼10 days would greatly overlap with the histogram of NI cells.
Since only a minor fraction of cells (<1%) falls under the auto-
fluorescence threshold at t¼10 days (see Supplementary Section
S2) and eight divisions are required for an H2B-GFP labeled cell
to become GFPneg, 30 h were selected as the lower bound for the
mean of the division interval for both proliferating and fast pro-
liferating cells;
• the threshold between slowly and fast proliferating cells was
chosen similarly to the previous reasoning: if slowly proliferat-
ing cells divided more than 8 times during the t¼21 days time
span, the experimental histograms would appear with zero
frequency for fluorescence levels between 101 and 103. Hence,
the threshold between slowly and fast proliferating cells was set
to 63 h;
• the ranges of values for the SD were chosen coherently with the
mean of the division interval for each subpopulation type, and
reasonably large to avoid the possibility of determining a search
space that does not include the optimal solution.
The optimization process carried out by FST-PSO is realized by eval-
uating, at each iteration, the ‘quality’ of the position of each particle
in the search space (that is, the goodness of the candidate model par-
ameterization) by means of a so-called fitness function. This is ne-
cessary to identify the current global and local best particles, and to
update the position of each particle. In this work, since each particle
represents a candidate model parameterization, the fitness function
of a particle consists in comparing the histogram corresponding to
the experimental data with the histogram generated by simulating
each model of cell proliferation using the parameterization codified
by that particle (see Section 3.2).
3 Algorithm
3.1 ProCell: stochastic simulation of cell proliferation
ProCell is a novel, general-purpose stochastic algorithm that allows
to simulate cell division in a population of proliferating cells. Here
we apply ProCell in the context of AML considering the configur-
ation of subpopulations defined in Models #1–#4 (see Table 1), and
taking into account that cell fluorescence is halved after each cell
division due to GFP-marked chromatin separation, as described in
Section 2.1. Figure 1 shows that (slowly and fast) proliferating cells
can stochastically divide at different time instants during the simula-
tion, generating two daughter cells with halved fluorescence levels.
Note that quiescent cells never divide and keep their initial fluores-
cence level unaltered till the end of the simulation. ProCell accounts
for this stochasticity since the exact timing of each cell division is
not fixed a priori, but it is a random variable sampled at each iter-
ation from a truncated normal distribution Nðl; rÞ, for some mean
division interval l and SD r. Given a model of cell proliferation, an
arbitrary model parameterization x, an initial histogram of fluores-
cence levels and a specific threshold umin, ProCell generates the pre-
dicted output histogram H(t) that represents the frequency
distribution of simulated GFPpos cells at time t. Precisely, the input
of ProCell consists in the following data:
• the histogram H(0) of the initial fluorescence levels (as defined in
Section 2.2, assuming t¼0);
• the threshold umin of H2B-GFP specific cell fluorescence
detection;
Table 2. Range of parameter values used by FST-PSO (time
expressed in hours)
Proliferating Slowly
proliferating
Fast
proliferating
Proportion
lp rp ls rs lf rf pq pf
½30; 504 [0:01; 40] [63, 504] [0:01; 40] [30, 63] [0:01; 30] [0, 1] [0, 1]
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• the vector s of the cell types in the population;
• the proportions of cell types p in the population, where
p ¼ ½0; 1jsj;
• the vector l of the mean division intervals for non-quiescent
cells;
• the vector r of the SD of division intervals for non-quiescent
cells;
• the number of hours tmax to be simulated.
ProCell’s output is the final histogram of the population after tmax
hours.
ProCell relies on a stack of cell objects. Each cell is characterized
by four attributes: (i) the cell type; (ii) the fluorescence level; (iii) the
timer, denoting the waiting time before the cell’s next division; (iv)
the current simulation time instant t.
The first step of ProCell consists in creating a stack of cells
(see Listing 1). Specifically, ProCell begins by fetching couples
ðui;wiÞ from the initial histogram H(0) (Line 3). For each couple,
exactly wi cells with fluorescence level ui are created (Lines 4–5).
The total number of cells pushed on the stack is equal to the cu-
mulative frequency of the histogram, i.e.
XM
i¼1 wi, where M is the
number of different fluorescence levels in H(0). When a new cell
is created, it is assigned to one of the available population types.
The type of the new cell is randomly chosen with a probability
proportional to the user-specified proportions (Line 6). In the list-
ing, UðÞ denotes a number randomly chosen from a uniform distri-
bution in ½0; 1. In the context of AML we consider the following
cell types: quiescent (q), proliferating (p), slowly proliferating (s),
and fast proliferating (f) cells. The vector p of the proportions of
cell subpopulations appearing in each model of cell proliferation
in AML is unknown, and is estimated at run time by coupling the
simulation of cell divisions with FST-PSO, as described in Section
3.2. If the cell is quiescent, its timer is set to infinity (Line 9);
otherwise, its timer is set by randomly sampling the waiting time
from a truncated normal distribution with the user-specified
mean and SD (Line 11). Cells are not synchronized, that is, they
can be in any phase of the cell-cycle. Hence, the initial time t of
the cell is set to an arbitrary value of its waiting time. This is
achieved by multiplying a random sample from a truncated nor-
mal distribution, with the user-specified mean and SD, by UðÞ
(Line 13). In the context of AML, both the vectors of the mean (l)
and SD (r) values of division intervals for all cell types appearing
in the four models are not known and need to be estimated at run
time. When the creation process is completed, the cell is pushed
on the stack (Line 14).
Listing 1. Initialization of the cells’ stack
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
The simulation algorithm at the basis of ProCell is shown in
Listing 2. As a first step, ProCell creates a container (in our imple-
mentation, a dictionary) that collects the final fluorescence levels
after tmax hours (Line 2). Then, as long as the cell stack is not empty
(Line 3), cell divisions are repeatedly performed. During each iter-
ation, a cell is popped out of the stack and its type is determined. If
the cell is quiescent, by definition, it does not divide and its initial
fluorescence level is conserved until the end of the simulation.
Hence, a new hit of that specific fluorescence level is directly added
to the dictionary (Lines 5–6).
If the cell is not quiescent, it can undergo division. The algo-
rithm verifies whether the waiting time before the next division
will exceed the maximum simulation time tmax. If the calculated
division interval is greater than tmax, the cell will not divide before
the end of the simulation and a new hit of its current fluorescence
level is added to the dictionary (Lines 23–24). On the contrary, if
the calculated division interval is smaller than or equal to tmax,
then the simulation time of the cell is updated (Line 9) and the
fluorescence level of the two daughter cells is verified: as soon as
the fluorescence level drops below the threshold umin, the corre-
sponding cell is removed from the simulation (Line 10) since it
cannot be detected as GFPpos by the experimental
instrumentation.
Fig. 1. Scheme of ProCell functioning. Quiescent cells (salmon) never divide
and keep their initial fluorescence level unaltered. Slowly and fast proliferat-
ing cells (cyan and green, respectively) stochastically divide at different time
instants, generating daughter cells with halved fluorescence levels. When the
maximum simulation time is reached, the fluorescence distribution of the
final cell population is returned
3382 M.S.Nobile et al.
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Listing 2. Simulation algorithm
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
If the fluorescence level remains above the threshold, two new
cell objects are created. These new cells inherit the halved fluores-
cence levels (Lines 11–12), the current simulation time (Lines 13–
14), and the type (Lines 15–17) from the parent cell. The waiting
time before the next cell division is not directly inherited from the
parent cell, but it is sampled from the user-specified truncated nor-
mal distribution according to the cell type (Lines 18–19). Finally,
the new cells are pushed on the stack (Lines 20–21). The simulator
iterates until the stack is empty; when the simulation is over, the dic-
tionary representing the histogram of the fluorescence distribution
at tmax is returned (Line 28).
It is worth noting that, given any non-quiescent cell in the stack,
the sequence of its divisions halts under two circumstances: when
the simulation time reaches tmax, or when the fluorescence levels of
its daughter cells fall below the threshold umin. The latter circum-
stance is more likely to occur for proliferating cells characterized by
a low initial fluorescence level, especially in the case of fast prolifer-
ating cells. The thresholding of the fluorescence level reflects the ac-
tual laboratory reality and mitigates the exponential growth of the
stack size.
3.2 Parameter estimation of cell proliferation models
Given an initial histogram of fluorescence levels H(0) and a vector
of model parameters (i.e. x ¼ hpq; pp; ps; pf ;lp; rp; ls; rs; lf ;rf i in
the context of AML), the algorithm given in Listing 2 is used to
simulate cell proliferation for each subpopulation type. In this work,
each model presented in Table 1 is instantiated by setting to zero the
proportion of each subpopulation that is not explicitly considered in
that model. For instance, Model #1 is obtained by setting pq ¼ ps ¼
pf ¼ 0 in x, so that only proliferating cells are created in the stack of
cells according to Listing 1.
The parameters in x are unknown for the cell proliferation mod-
els in human AML xenografts, and were estimated by means of the
FST-PSO algorithm. During the execution of FST-PSO, each candi-
date parameterization codified by a particle is used to perform an in-
dependent simulation of cell proliferation with ProCell; the fitness
function of the parameterization is calculated as the distance be-
tween the simulated histogram and the experimental histogram of
the fluorescence values sampled after a fixed amount of time tmax.
Specifically, the measure used to assess the fitness function is the
Hellinger distance (see Nikulin, 2001 for further information). The
rationale of our fitness function—along with the binning and nor-
malization procedures used to make the target and simulated distri-
butions directly comparable—are described in Supplementary
Section S3. In all fitness evaluations, we set umin to the minimum
fluorescence level in the target histogram. In order to analyze the
average behavior of FST-PSO, for each model we run K¼30 inde-
pendent runs of the cell division algorithm coupled with FST-PSO,
and collect statistics about the best solution found at the end of the
optimization process.
Both ProCell and the parameter estimation methodology were
implemented in Python, exploiting the libraries numpy v1.13.3
(Oliphant, 2007), scipy v1.0.1 (Jones et al., 2001), fst-pso v1.4.8
(Nobile et al., 2018b) and miniful v0.0.4. In order to accelerate the
fitness function evaluations, we exploited the Python multiprocess-
ing facility to parallelize the simulations of the particles over mul-
tiple cores. Moreover, we further increased the level of parallelism
by executing multiple independent runs of FST-PSO on a multi-node
supercomputer (CINECA’s Marconi).
4 Results
4.1 Model calibration
The parameters of each model of cell proliferation (Table 1) were
calibrated by means of FST-PSO, exploiting the leukemic blasts col-
lected from the BM of AML xenografts. The simulated histograms
were calculated starting from an experimental initial histogram of
fluorescence levels H(0) and fitted against the experimental target
histograms according to the fluorescence of the cells harvested after
tmax¼240 h of chasing, as described in Section 3.2. Figure 2 shows
a swarm plot (SP) of the optimal solutions found in K¼30 runs for
each model (organized along the x axis). A SP is a special type of
scatterplot, in which data are distributed along the y axis according
to their values. The peculiarity of SP is that points with similar qual-
ity are packed but displaced along the x axis, to avoid any overlap
and to give an optimal perception of the distribution of data. In
Figure 2, data represent the fitness values, i.e. the Hellinger distance
between each optimal solution and the target experimental histo-
gram. According to this SP, Models #3 and #4 (dark green and blue,
respectively) achieve a better fitting of the target distributions with
respect to Models #1 and #2 (red and light green, respectively).
Interestingly, Figure 2 highlights that Models #1 and #2 always con-
verge to solutions with the same quality; on the contrary, the fitness
landscapes associated with Models #3 and #4 are characterized by a
local optimum, represented by the clusters of solutions characterized
by a Hellinger distance value approximately equal to 18. This cir-
cumstance is due to the stochastic initialization of particles’ position
(see Supplementary Section S4 for a detailed explanation). This re-
sult emphasizes the importance of performing multiple repetitions
(e.g. K30) of the parameter estimation task, instead of relying on a
single outcome of the optimization procedure. As a matter of fact,
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this approach is preferable as it reduces the probability to find out a
‘low quality’ model parameterization, corresponding to a particle
stuck into one of the local minima. Therefore, considering K¼30
runs of FST-PSO, we report in Table 3 the best parameterization
found for each model of cell proliferation.
The best parameterizations found across the K repetitions were
used to perform a simulation of cell proliferation with ProCell, and
to visually inspect the quality of the solutions. In Figure 3 we show
the comparison between the experimental histograms (green bars)
and the simulated histograms (red bars) for each cell proliferation
model, obtained using the best model parameterizations listed in
Table 3. These results further confirm that Models #3 and #4 better
overlap the target histogram with respect to Models #1 and #2.
The inset figures show the right tail of the distribution: this
region highlights the role of quiescent cells, since only Models #2 and
#3 are able to fit this specific part of the histogram. Finally, the bars
on the top of Figure 4 show the Hellinger distances between the
target distribution and the simulated distribution evaluated using
the best model parameterizations found by FST-PSO, and further
confirm that Model #3 provides the best explanation for the experi-
mental data.
Altogether, these results suggest that, on the one hand, a naı¨ve
distinction between quiescent and proliferating cells in the popula-
tion (i.e. Model #2) is not sufficient to reproduce the fluorescence
levels measured after tmax¼240 h of chasing, even though these two
subpopulations help to partially describe the high-fluorescence tail
of the histogram. On the other hand, the distinction between two
types of proliferating cells with different average division intervals
(i.e. slowly and fast proliferating cells in Model #4) has a stronger
impact on the overall population dynamics. In fact, our results indi-
cate that it is the simultaneous presence of quiescent, slowly prolifer-
ating and fast proliferating cells in the population (i.e. Model #3)
that is able to reproduce at best the experimental data.
At this point, we wanted to exclude the possibility that the
good fit obtained by Model #3 was due to the larger number of its
free parameters with respect to the other three models. We per-
formed a tailored analysis by defining an additional model charac-
terized by a larger number of free parameters, named Model #5.
According to our results, we can affirm that Model #3 represents
the simplest and the most likely explanation for the observed
phenomena (see Supplementary Section S5 for more details).
Moreover, since some works reported the gamma distribution
(Kinjyo et al., 2015; Stukalin et al., 2013) as a putative distribution
of cell division times, we repeated the parameter estimation of the
five models exploiting this distribution. The results of this analysis
(reported in Supplementary Section S6) show that, in this particular
context, models adopting the gamma distribution do not provide
more fitting solutions with respect to the ones adopting the normal
distribution.
Table 3. Best parameterizations found by FST-PSO
lpðrpÞ lsðrsÞ lf ðrf Þ pq : pp : ps : pf
Model #1 46.1 (28.9) — —  : 1 :  : 
Model #2 46.0 (26.4) — — 0.14 : 0.86 :  : 
Model #3 — 63.7 (28.9) 41.1 (14.3) 0.06 :  : 0.47 : 0.47
Model #4 — 83.9 (26.6) 44.2 (19.5)  :  : 0:28 : 0:72
Note: Time expressed in hours.
Fig. 3. Comparison between the target histogram (green bars) and the simu-
lated histogram (red bars) obtained at tmax¼240 h. Simulations were run
with the best parameterizations found by FST-PSO for each cell proliferation
model. The inset represents the right tail of the histogram, i.e. cells whose
fluorescence is above 103
Fig. 2. Results of the parameter estimation over the four competing models,
shown as SPs of the solutions found (the lower, the better). Models #3 (dark
green) and #4 (blue) achieve the best fitting with the experimental histograms
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We conclude that the H2B-GFP dilution profile at day 10 is con-
sistent with the persistence of quiescent and slowly proliferating cell
subpopulations during the exponential phase of leukemia develop-
ment in our xenotransplantation model. Importantly, according to
the best parameterization of Model #3 estimated by FST-PSO, only
47% of the initial leukemic population (day 0) appears to divide
rapidly to fuel tumor growth.
4.2 Model validation
To validate the predictive capability of Model #3, we simulated cell
proliferation up to tmax¼504 h (i.e. 21 days) using the best param-
eterization found by FST-PSO. This time interval was chosen as the
maximum chasing period experimentally implemented, in order to
avoid unnecessary animal suffering. Notably, at the end of the 3-
week chasing, <1% of the leukemic cells retained a high intensity
GFP signal. We show in Figure 5 the outcome of Model #3 valid-
ation. According to our results, the predicted distribution obtained
with the best parameterization given in Table 3 still fits with the ex-
perimental data measured at tmax¼504 h. For the sake of complete-
ness, we carried out the validation of the other three models of cell
proliferation, and calculated the Hellinger distance on the predicted
distributions generated by their best parameterizations, as given in
Table 3. The bars on the bottom of Figure 4 further confirm that
Model #3 is characterized by the most fitting behavior (even better
than Model #5, as shown in Supplementary Section S5), therefore
consolidating the theory that Model #3 is the most likely model of
cell proliferation in AML.
In conclusion, our analysis demonstrates that the analyzed BM
samples of AML xenografts are composed of populations with high-
ly heterogeneous proliferative potential. According to the best par-
ameterization found by FST-PSO (Table 3), in the analyzed
timeframe only 47% of the initial population of cells can be
considered as fast proliferating, with a division event occurring ap-
proximately every 2 days. Instead, an equal fraction of the popula-
tion at the start of the chasing period was found to proliferate at a
slower rate (with a division interval of about 3 days), while 6%
remains undivided for the entire chasing period. We consider this
latter population of label-retaining cells as bona fide quiescent leu-
kemic blasts.
5 Conclusion
The stochastic modeling approach presented here provides new
insights on the intricate cellular organization of AML, highlighting
the existence of slowly proliferating and long-term quiescent leu-
kemic cells in vivo. Notably, based on the comparison of different
models of cell proliferation and on their best parameterizations
found by FST-PSO, 1 in 20 leukemic blasts of the initial popula-
tion at day 0 is predicted to remain quiescent during a chasing
period of 3 weeks. In addition, around half of the blasts at day 0 are
predicted to contribute in fueling tumor growth, albeit with a lower
cell turnover. This complex scenario, depicted by Model #3, could
have important clinical implications in the context of disease recur-
rence, since most therapeutic approaches target mainly highly prolif-
erating cells. Quiescent/slowly dividing cells, instead, could evade
aggressive chemotherapeutic treatment, and drive tumor evolution
and adaptation under harsh environmental challenges. Thus, our
in vivo H2B-GFP label-retaining assay establishes an ideal experi-
mental setting for the isolation of viable leukemic cells with distinct
proliferation properties, allowing further manipulation aiming at
their functional, transcriptional and genomic characterization, with
the ultimate goal of revealing intrinsic vulnerabilities and novel
therapeutic targets.
To our knowledge, this is the first attempt to decipher in vivo
cell-cycle and proliferation kinetics in AML xenografts. Similar
studies have been performed, instead, on the normal HSC counter-
part, using H2B-GFP, CFSE or BrdU label-dilution flow cytometry
data after long-term in vivo chasing periods (Bernitz et al., 2016;
Foudi et al., 2009; Takizawa et al., 2011; Wilson et al., 2008).
Depending on the study, active HSCs appear to divide once in about
every 10–36 days, while the dormant ones are estimated to enter
cell-cycle every 100–150 days (Takizawa et al., 2011; Wilson et al.,
2008). In contrast to studies on normal hematopoiesis, leukemia
progression imposes strict limitations on the length of the chasing
periods that can be safely applied, due to animal welfare reasons.
Nevertheless, in all cases, dividing leukemia blasts exhibited faster
kinetics in our PDX model (2.7 days for the slowly dividing, and
1.7 days for the fast dividing cells), while quiescent cells were de-
tectable even after 6 weeks of continuous dox treatment. We plan to
further optimize our experimental setting, to allow monitoring of
cell proliferation within wider timeframes.
From the computational point of view, although the relevant
running time required by ProCell was strongly reduced by the com-
bined use of multi-threading and distributed computation over
multi-node clusters, simulating the temporal evolution of cell popu-
lations is still very time consuming. As future developments, we plan
to realize a novel implementation of ProCell that exploits the com-
puting power of modern graphics processing units (GPUs). GPUs are
massive multi-core co-processors capable of drastically reducing the
running time required by any computational tool, paving the way to
thorough investigations of biological systems (Nobile et al., 2017).
Specifically, we will re-implement ProCell using the Cþþ language
and the Nvidia CUDA library. Moreover, we plan to leverage
Fig. 4. Comparison of the Hellinger distances between the experimental and
the simulated histograms at tmax¼240 h for model calibration (bars on the
top), and tmax¼ 504 h for model validation (bars on the bottom). The simula-
tions were performed using the best parameterization found by FST-PSO. A
lower Hellinger distance corresponds to a better result: Model #3 represents
the best explanation for cell proliferation in AML
Fig. 5. Validation of Model #3: the predicted distribution (red bars) fits with
the experimental data (green bars) at tmax¼ 504 h
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CUDA’s dynamic parallelism in order to recursively spawn new
threads on the GPU as soon as a cell divides. Ad hoc data structures
for histogram accumulation and storage—combined with atomic
mathematical functions to prevent critical runs—will provide a
strong reduction of the overall computation time, allowing more
complex analyses at the cell population level.
To determine the parameters of cell proliferation models, the
computational framework presented in this work exploits the
settings-free algorithm FST-PSO. So doing, the input of our compu-
tational framework is reduced only to the vector of cell types and
the ranges of the parameter values, thus facilitating users without
programing or computational expertise to run experiments with
ProCell.
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